Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Multiple-site, Phase I/II Dose Cohort Trial of [6R] 5,10-Methylene Tetrahydrofolate (Modufolin®) in Combination With a Fixed Dose of 5-Fluorouracil (5-FU) Alone or Together With a Fixed Dose of Oxaliplatin or Irinotecan in Patients With Stage IV Colorectal Cancer

NCT02244632 is registered in ClinicalTrials.gov with Isofol Medical AB as lead sponsor.

NCT NCT02244632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02244632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Multiple-site, Phase I/II Dose Cohort Trial of [6R] 5,10-Methylene Tetrahydrofolate (Modufolin®) in Combination With a Fixed Dose of 5-Fluorouracil (5-FU) Alone or Together With a Fixed Dose of Oxaliplatin or Irinotecan in Patients With Stage IV Colorectal Cancer
Lead sponsor
Isofol Medical AB
Phase
Phase 1/2
Overall status
Completed
Start date
September 30, 2014
Completion date
January 30, 2020
Enrollment
105 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal neoplasm